Yichao Shen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 13

Top Topics

Sentinel Lymph Node

Regulatory T Cells

Epidermal Growth Factor Receptor

Top Venues

Science advances

Cancer research

Molecular cancer therapeutics

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Oluwatoyosi Adewunmi, Yichao Shen, Xiang H F Zhang, Jeffrey M Rosen
Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple negative breast cancer. Cancer immunology research (2023)
Yi-Hsuan Wu, Zbigniew Gugala, Megan M Barry, Yichao Shen, Subhamoy Dasgupta, Hai Wang
Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis. Molecular cancer therapeutics 21 (8) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Weijie Zhang, Zhan Xu, Xiaoxin Hao, Tiancheng He, Jiasong Li, Yichao Shen, Kai Liu, Yang Gao, Jun Liu, David Edwards, Aaron M Muscarella, Ling Wu, Liqun Yu, Longyong Xu, Xi Chen, Yi-Hsuan Wu, Igor L Bado, Yunfeng Ding, Sergio Aguirre, Hai Wang, Zbigniew Gugala, Robert L Satcher, Stephen T C Wong, Xiang H F Zhang
Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells. Cancer discovery (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Swarnima Singh, Nigel Lee, Diego A Pedroza, Igor L Bado, Clark Hamor, Licheng Zhang, Sergio Aguirre, Jingyuan Hu, Yichao Shen, Yitian Xu, Yang Gao, Na Zhao, Shu-Hsia Chen, Ying-Wooi Wan, Zhandong Liu, Jeffrey T Chang, Daniel Hollern, Charles M Perou, Xiang H F Zhang, Jeffrey M Rosen
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer research 82 (12) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)